相关实验视频

Updated: Sep 19, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

使用PSMA PET/CT进行前列腺癌治疗反应评估

Andrei Gafita^1,2, Jennifer A Schroeder³, Francesco Ceci⁴

¹Division of Nuclear Medicine and Molecular Imaging, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; agafita1@jhmi.edu steven_rowe@med.unc.edu.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

|June 5, 2025

概括

前列腺特异性膜抗原 (PSMA) 向的PET越来越多地用于前列腺癌 (PC) 的分期. 虽然它对分期和治疗资格有价值,但它在响应评估中的作用需要进一步研究,特别是在新疗法中.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

前列腺特异性膜抗原 (PSMA) 向的PET成像在前列腺癌 (PC) 管理中获得了突出地位.
对于PSMA PET在分阶段,复发检测和治疗资格方面存在监管批准.
传统的成像 (CT,骨扫描) 和非PSMA PET 标记器在PC检测和响应评估方面存在局限性.

研究的目的:

评估目前PSMA PET在前列腺癌中的应用和局限性.
讨论PC中PSMA PET现有的响应评估标准是否合适.
探索PSMA PET在PC治疗监测中的未来方向.

主要方法:

对前列腺癌中PSMA PET的当前文献和监管批准的审查.
在不同治疗环境中分析PSMA PET进展标准和RECIP 1.0的实用性.
讨论评估PSMA PET治疗反应的挑战,特别是与雄激素信号轴抑制剂.

主要成果:

PSMA PET被批准用于初始分期,复发检测和指导PSMA向放射性药物治疗.
目前的响应评估方法通常不适合PC,PSMA PET缺乏针对此用途的具体监管批准.
由于PSMA PET进展标准和RECIP 1.0在细胞毒性疗法中具有价值,但由于PSMA表达的变化,与色素向剂的作用不太清楚.

结论:

在前列腺癌中,PSMA PET是分期和治疗选择的关键工具.
需要进一步的研究,以建立使用PSMA PET的标准化响应评估标准.
机器学习和人工智能可能会从治疗期间PSMA PET吸收变化中识别出新的成像生物标志物.

关键词:

这就是PPP PPP PPP.在PSMA上,PSMA可以在PSMA上进行交易.在RECIP中使用RECIP.前列腺癌是前列腺癌.前列腺特异性膜抗原前列腺特异性膜抗原放射性药物疗法是一种放射性药物疗法.响应评估响应评估响应评估

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET